These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 22665688)

  • 41. Diagnosis and management of Alzheimer's disease.
    Coll PP; Fortinsky RH; Kaplan R; Song C
    Conn Med; 2003 Sep; 67(8):505-10. PubMed ID: 14587132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
    Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
    Farlow MR
    Mayo Clin Proc; 2006 Oct; 81(10):1350-8. PubMed ID: 17036561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacology of Alzheimer's disease: where do we go from here?].
    Sellal F; Nieoullon A; Michel G; Michel BF; Lacomblez L; Geerts H; Delini-Stula A; Bentué-Ferrer D; Bordet R; Allain H
    Therapie; 2005; 60(2):89-107. PubMed ID: 15969312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alzheimer's disease.
    Cummings JL
    N Engl J Med; 2004 Jul; 351(1):56-67. PubMed ID: 15229308
    [No Abstract]   [Full Text] [Related]  

  • 49. A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease.
    Ebrahem AS; Oremus M
    Expert Opin Pharmacother; 2018 Aug; 19(11):1245-1259. PubMed ID: 29999427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current treatment of mild cognitive impairment and Alzheimer's disease.
    Knopman DS
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):365-71. PubMed ID: 16928345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination Drug Therapy for the Management of Alzheimer's Disease.
    Kabir MT; Uddin MS; Mamun AA; Jeandet P; Aleya L; Mansouri RA; Ashraf GM; Mathew B; Bin-Jumah MN; Abdel-Daim MM
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does this patient have Alzheimer disease? Diagnosing and treating dementia.
    Messinger-Rapport BJ
    Cleve Clin J Med; 2003 Sep; 70(9):762, 764, 766-70 passim. PubMed ID: 14518571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alzheimer's disease].
    Jedidi H; Jedidi Z; Salmon E
    Rev Med Liege; 2010 Mar; 65(3):163-8. PubMed ID: 20411822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacological and non-pharmacological treatment of Alzheimer's dementia].
    Wallesch CW
    MMW Fortschr Med; 2013 May; 155(8):60-2. PubMed ID: 24437141
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions.
    Marksteiner J; Schmidt R
    Drugs Aging; 2004; 21(7):415-26. PubMed ID: 15132710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Capabilities of combined therapy of Alzheimer's disease].
    Vasenina EE; Veryugina NI; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):45-50. PubMed ID: 36412156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.
    Loi SM; Eratne D; Kelso W; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):358-365. PubMed ID: 29671334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Drug treatment of Alzheimer's dementia : Status quo and perspectives].
    Müller P; Fendt M; Müller NG
    Internist (Berl); 2019 Jul; 60(7):761-768. PubMed ID: 31139854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance of high quality trials of cognitive interventions in Alzheimer's disease.
    Huntley J; Howard R
    Int Psychogeriatr; 2016 May; 28(5):705-6. PubMed ID: 27032538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.